These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 5514382)

  • 1. L-dopa: effect on highest integrative functions in Parkinsonism.
    Guthrie TC; Dunbar HS; Weider A
    Trans Am Neurol Assoc; 1970; 95():250-2. PubMed ID: 5514382
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of L-dopa on individual symptoms of parkinsonism.
    Boshes B; Blonsky ER; Arbit J; Klein K
    Trans Am Neurol Assoc; 1969; 94():229-31. PubMed ID: 5374443
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism.
    Knutsson E; Mårtensson A; Meyerson BA; Risberg AM
    Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled study of the effect of L-dopa upon selected cognitive and behavioral functions.
    Boshes B; Arbit J
    Trans Am Neurol Assoc; 1970; 95():59-63. PubMed ID: 4936414
    [No Abstract]   [Full Text] [Related]  

  • 5. The modifying influence of L-dopa on the physical therapy program in Parkinson's disease.
    Blonsky ER; Minnigh EC
    Prog Phys Ther; 1970; 1(1):55-74. PubMed ID: 5523796
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evolution of intellectual potential and memory in Parkinsonism patients treated with L-dopa].
    Vernet JP; Novi M; Sevilla M; Becle J; Lavagna J; Darcourt G
    Ann Med Psychol (Paris); 1973 Mar; 1(3):413-27. PubMed ID: 4722004
    [No Abstract]   [Full Text] [Related]  

  • 7. L-dopa effects on motor and "central programming" deficits in Parkinsonism.
    Horne DJ
    Psychopharmacologia; 1974 Apr; 36(2):175-80. PubMed ID: 4407693
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychological studies of longer range L-DOPA therapy in Parkinsonism.
    Riklan M; Halgin R; Maskin M; Weissman D
    J Nerv Ment Dis; 1973 Dec; 157(6):452-64. PubMed ID: 4148472
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Trans Am Neurol Assoc; 1969; 94():348-50. PubMed ID: 5374483
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative effects of L-dopa on different types of movements and muscle tone in Parkinsonian patients.
    Knutsson E; Mårtensson A
    Scand J Rehabil Med; 1971; 3(3):121-30. PubMed ID: 5156174
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot study with cyclobenzaprine in idiopathic Parkinsonism.
    Korten JJ; van Hemert J
    Psychiatr Neurol Neurochir; 1973; 76(2):119-28. PubMed ID: 4700930
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F; Grünberger J; Schubert H
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Rey complex picture test in evaluation of some effects induced by treatment with L-dopa in patients with parkinsonism].
    Megna GF; Puca FM; Micalizzi V; Leggiadro N; Di Rosa AE
    Acta Neurol (Napoli); 1971; 26(4):473-83. PubMed ID: 4943712
    [No Abstract]   [Full Text] [Related]  

  • 14. L-dopa and parkinsonism.
    Okihiro MM
    Hawaii Med J; 1971; 30(5):390-2. PubMed ID: 5160226
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of parkinsonism with L-dopa].
    Chouza C; Marín C; Romero S; Gomensoro JB
    Acta Neurol Latinoam; 1970; 16(1):170-83. PubMed ID: 5538052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of parkinsonism with L-dopa].
    Hernández Peniche J; Martínez Villar C; De León Charles C
    Rev Invest Clin; 1971; 23(2):125-32. PubMed ID: 5114336
    [No Abstract]   [Full Text] [Related]  

  • 17. [Parkinsonism and L-dopa: our 1st results].
    Warot P; Petit H; Chevalier-Lefebvre J; Herbaut G
    Lille Med; 1971 May; 16(5):765-7. PubMed ID: 5115349
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of L-dopa on mental functions in parkinsonism].
    Violon A; Peypers J; Rappel M
    Acta Psychiatr Belg; 1972 Mar; 72(2):168-84. PubMed ID: 5056014
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on patients with Parkinson's disease treated with L-dopa. I. Trial and evaluation of L-dopa therapy.
    van Wieringen A; Wright J
    S Afr Med J; 1972 Sep; 46(35):1262-6. PubMed ID: 4638222
    [No Abstract]   [Full Text] [Related]  

  • 20. Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa.
    Donnelly EF; Chase TN
    Dis Nerv Syst; 1973 Feb; 34(2):119-23. PubMed ID: 4706860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.